Key facts
- Notable investors include Green Pine Capital Partners, Guangdong Academy of Greater Bay Area Studies, Guangdong Collaborative Innovation Industry Investment, Guangzhou Guangping Pingyun Capital Management, Guangzhou Industrial Investment Holding Group — 10 tracked in total.
- Status: Privately Held (backing).
Investors
10- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Ximang Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ximang Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ximang Medical
Developer of brain-computer interface platforms designed to advance medical applications. The company offers Aci-EM Digital EEG system, designed to collect, monitor, and process brainwave data for clinical diagnostics, thereby enabling real-time monitoring and playback of EEG data to assist in diagnosing patients' cognitive brain functions.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2022
- Website
- acimicro.com/
- Ownership
- Privately Held (backing)
Ximang Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ximang Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ximang Medical in its N-PORT filings yet. We sweep new filings monthly.